These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4716799)

  • 41. The effect of butylated hydroxytoluene on the growth of enzyme-altered foci in male Fischer 344 rat liver tissue.
    Lok E; Mehta R; Jee P; Laver G; Nera EA; McMullen E; Clayson DB
    Carcinogenesis; 1995 May; 16(5):1071-8. PubMed ID: 7767967
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of ovariectomy on the in vitro and in vivo activation of carcinogenic N-2-fluorenylhydroxamic acids by rat mammary gland and liver.
    Ritter CL; Bennett KK; Fullerton NF; Beland FA; Malejka-Giganti D
    Carcinogenesis; 1996 Nov; 17(11):2411-8. PubMed ID: 8968056
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of promutagen activation by the antioxidants butylated hydroxyanisole and butylated hydroxytoluene.
    McKee RH; Tometsko AM
    J Natl Cancer Inst; 1979 Aug; 63(2):473-7. PubMed ID: 287836
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibitory effect of butylated hydroxytoluene (BHT) on intestinal carcinogenesis in rats by azoxymethane.
    Weisburger EK; Evarts RP
    Food Cosmet Toxicol; 1977 Apr; 15(2):139-41. PubMed ID: 873406
    [No Abstract]   [Full Text] [Related]  

  • 45. Transport of carcinogens: rat blood plasma and red cell binding of isotope after N-hydroxy-N-2-fluorenylacetamide.
    Weisburger JH; Grantham PH; Weisburger EK
    Life Sci; 1966 Jan; 5(1):41-5. PubMed ID: 5933654
    [No Abstract]   [Full Text] [Related]  

  • 46. Chloramphenicol, protein synthesis, and the metabolism of the carcinogen N-2-fluorenyldiacetamide in rats. Inhibition by chloramphenicol of carcinogen binding.
    Weisburger JH; Shirasu Y; Grantham PH; Weisburger EK
    J Biol Chem; 1967 Feb; 242(3):372-8. PubMed ID: 6022834
    [No Abstract]   [Full Text] [Related]  

  • 47. Hormones, chemicals and liver cancer.
    Weisburger JH
    N Z Med J; 1968 Jan; 67(426):Suppl:44-58. PubMed ID: 5238937
    [No Abstract]   [Full Text] [Related]  

  • 48. 8-hydroxyquinoline: chronic toxicity and inhibitory effect on the carcinogenicity of N-2-fluorenylacetamide.
    Yamamoto RS; Williams GM; Frankel HH; Weisburger JH
    Toxicol Appl Pharmacol; 1971 Aug; 19(4):687-98. PubMed ID: 5132036
    [No Abstract]   [Full Text] [Related]  

  • 49. Preferential binding of 2-acetylaminofluorene to rat liver rRNA during early stages of hepatocarcinogenesis.
    Irving CC; Veazey RA
    Biochem Biophys Res Commun; 1972 Jun; 47(5):1159-64. PubMed ID: 5029863
    [No Abstract]   [Full Text] [Related]  

  • 50. Toxic effects of butylated hydroxytoluene on rats.
    Saheb JL; Saheb SA
    Can J Comp Med; 1977 Apr; 41(2):195-201. PubMed ID: 861837
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The conversion of the carcinogen N-hydroxy-2-fluorenylacetamide to o-amidophenols by rat liver in vitro. An inducible enzymatic reaction.
    Gutmann HR; Erickson RR
    J Biol Chem; 1969 Apr; 244(7):1729-40. PubMed ID: 5780838
    [No Abstract]   [Full Text] [Related]  

  • 52. Conjugation of phenolic steroid ring D alpha-ketols in human pregnancy urine.
    Tan SY; Anuman-Rajadhon Y; Hobkirk R
    Clin Chim Acta; 1971 Feb; 31(2):387-93. PubMed ID: 4324799
    [No Abstract]   [Full Text] [Related]  

  • 53. On the correlation between the hepatocarcinogenicity of the carcinogen, N-2-fluorenylacetamide, and its metabolic activation by the rat.
    Gutmann HR; Malejka-Giganti D; Barry EJ; Rydell RE
    Cancer Res; 1972 Jul; 32(7):1554-61. PubMed ID: 4337834
    [No Abstract]   [Full Text] [Related]  

  • 54. THE METABOLISM OF N-2-FLUORENYLACETAMIDE IN THE CAT: EVIDENCE FOR GLUCURONIC ACID CONJUGATES.
    WEISBURGER JH; GRANTHAM PH; WEISBURGER EK
    Biochem Pharmacol; 1964 Mar; 13():469-75. PubMed ID: 14157609
    [No Abstract]   [Full Text] [Related]  

  • 55. Biliary excretion of the O-glucuronide of N-hydroxy-2-acetylamino-fluorene by the rat and rabbit.
    Irving CC; Wiseman R; Hill JT
    Cancer Res; 1967 Dec; 27(12):2309-17. PubMed ID: 6082281
    [No Abstract]   [Full Text] [Related]  

  • 56. Isolation and identification of the carcinogen N-hydroxy-2-fluorenylacetamide and related compounds by liquid chromatography.
    Gutmann HR
    Anal Biochem; 1974 Apr; 58(2):469-78. PubMed ID: 4827393
    [No Abstract]   [Full Text] [Related]  

  • 57. Sex differences in cell proliferation and N-hydroxy-2-acetylaminofluorene sulfotransferase levels in rat liver during 2-acetylaminofluorene administration.
    Jackson CD; Irving CC
    Cancer Res; 1972 Jul; 32(7):1590-4. PubMed ID: 5030584
    [No Abstract]   [Full Text] [Related]  

  • 58. Persistent binding of 2-acetylaminofluorene to rat liver DNA in vivo and consideration of the mechanism of binding of N-hydroxy-2-acetylaminofluorene to rat liver nucleic acids.
    Irving CC; Veazey RA
    Cancer Res; 1969 Oct; 29(10):1799-804. PubMed ID: 5823948
    [No Abstract]   [Full Text] [Related]  

  • 59. BHT oxidase. A liver-microsomal enzyme induced by the treatment of rats with butylated hydroxytoluene.
    Gilbert D; Golberg L
    Food Cosmet Toxicol; 1967 Oct; 5(4):481-90. PubMed ID: 5582772
    [No Abstract]   [Full Text] [Related]  

  • 60. Enzymatic N-acetylation of carcinogenic aromatic amines by liver cytosol of species displaying different organ susceptibilities.
    Lower GM; Bryan GT
    Biochem Pharmacol; 1973 Jul; 22(13):1581-8. PubMed ID: 4729805
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.